Table 2.
The characteristic of patients, surgery, and anesthesia
| Age (years) | 48.7 ± 10.1 |
|---|---|
| Height (cm) | 159.2 ± 4.8 |
| Weight (kg) | 58.7 ± 10.5 |
| BMI (kg/m2) | 22.6 (20.7–24.4) |
| ASA I/II (%) | 20/17 (54.1/45.9) |
| Diagnosis/Operation name | |
| Polyp of endometrium/Endometrial polypectomy | 32 (86.5) |
| Myoma uteri/Hysteroscopic removal of leiomyoma | 4 (10.8) |
| Vaginal bleeding/Diagnostic hysteroscopic operation | 1 (2.7) |
| Time to modified OAA/S scale 0 (s) | 63.0 (54.0—76.8) |
| Time to BIS < 60 (s) | 135.0 (114.0—178.0) |
| Remimazolam dose until SGA insertion (mg/kg) | 0.40 (0.34—0.47) |
| Remifentanil dose until SGA insertion (μg/kg) | 1.07 (0.90 – 1.29) |
| Infusion rate of remimazolam during anesthesia maintenance (mg/kg/h) | 1.14 (0.88 – 1.55) |
| Infusion rate of remifentanil during anesthesia maintenance (μg/kg/min) | 0.06 (0.04 – 0.08) |
| Total anesthesia time (min) | 40.0 (40.0–57.5) |
| Recovery time (min) | 7 (5–8) |
| PACU length of stay (min) | 30.0 (22.5–34.5) |
ASA American society of anesthesiologists physical status, BMI Body mass index OAA/S Observer's assessment of alertness/sedation, BIS Bispectral index, PACU Postanesthesia care unit, SGA Supraglottic airway
Data are expressed as mean ± SD, median (IQR), or number (%)